Maria C. Dechecchi

Verona, 37134, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications

Assessing the Potential of N-Butyl-l-deoxynojirimycin (l-NBDNJ) in Models of Cystic Fibrosis as a Promising Antibacterial Agent.

Assessing the Potential of N-Butyl-l-deoxynojirimycin (l-NBDNJ) in Models of Cystic Fibrosis as a Promising Antibacterial Agent.

Journal: ACS pharmacology & translational science
Published: January 26, 2024

New TMA (4,6,4'-Trimethyl angelicin) Analogues as Anti-Inflammatory Agents in the Treatment of Cystic Fibrosis Lung Disease.

New TMA (4,6,4'-Trimethyl angelicin) Analogues as Anti-Inflammatory Agents in the Treatment of Cystic Fibrosis Lung Disease.

Journal: International journal of molecular sciences
Published: September 27, 2022

Improved Trimethylangelicin Analogs for Cystic Fibrosis: Design, Synthesis and Preliminary Screening.

Improved Trimethylangelicin Analogs for Cystic Fibrosis: Design, Synthesis and Preliminary Screening.

Journal: International journal of molecular sciences
Published: September 11, 2022

miRNAs in Serum Exosomes for Differential Diagnosis of Brain Metastases.

miRNAs in Serum Exosomes for Differential Diagnosis of Brain Metastases.

Journal: Cancers
Published: June 17, 2022

β-sitosterol ameliorates inflammation and Pseudomonas aeruginosa lung infection in a mouse model.

β-sitosterol ameliorates inflammation and Pseudomonas aeruginosa lung infection in a mouse model.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: February 22, 2022

Serum Exosomal microRNA-21, 222 and 124-3p as Noninvasive Predictive Biomarkers in Newly Diagnosed High-Grade Gliomas: A Prospective Study.

Serum Exosomal microRNA-21, 222 and 124-3p as Noninvasive Predictive Biomarkers in Newly Diagnosed High-Grade Gliomas: A Prospective Study.

Journal: Cancers
Published: April 27, 2021

A Peptide-Nucleic Acid Targeting miR-335-5p Enhances Expression of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene with the Possible Involvement of the CFTR Scaffolding Protein NHERF1.

A Peptide-Nucleic Acid Targeting miR-335-5p Enhances Expression of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene with the Possible Involvement of the CFTR Scaffolding Protein NHERF1.

Journal: Biomedicines
Published: November 02, 2020

A molecular signature associated with prolonged survival in glioblastoma patients treated with regorafenib.

A molecular signature associated with prolonged survival in glioblastoma patients treated with regorafenib.

Journal: Neuro-oncology
Published: July 15, 2020

Sphingolipids and plasma membrane hydrolases in human primary bronchial cells during differentiation and their altered patterns in cystic fibrosis.

Sphingolipids and plasma membrane hydrolases in human primary bronchial cells during differentiation and their altered patterns in cystic fibrosis.

Journal: Glycoconjugate journal
Published: May 23, 2020

GM1 as Adjuvant of Innovative Therapies for Cystic Fibrosis Disease.

GM1 as Adjuvant of Innovative Therapies for Cystic Fibrosis Disease.

Journal: International journal of molecular sciences
Published: May 14, 2020

Synthesis and Therapeutic Applications of Iminosugars in Cystic Fibrosis.

Synthesis and Therapeutic Applications of Iminosugars in Cystic Fibrosis.

Journal: International journal of molecular sciences
Published: April 27, 2020

Treatment of human airway epithelial Calu-3 cells with a peptide-nucleic acid (PNA) targeting the microRNA miR-101-3p is associated with increased expression of the cystic fibrosis Transmembrane Conductance Regulator () gene.

Treatment of human airway epithelial Calu-3 cells with a peptide-nucleic acid (PNA) targeting the microRNA miR-101-3p is associated with increased expression of the cystic fibrosis Transmembrane Conductance Regulator () gene.

Journal: European journal of medicinal chemistry
Published: March 31, 2020
Showing 1-12 of 37

Last Updated: 09/26/2026